News
RVTY
106.26
+6.37%
6.36
How Revvity’s New Signals AI-Powered R&D Platform (RVTY) Has Changed Its Investment Story
Simply Wall St · 8h ago
Barclays Remains a Hold on Revvity (RVTY)
TipRanks · 14h ago
Revvity launches Signals AI framework
TipRanks · 2d ago
Revvity Launches Signals AI
Benzinga · 2d ago
Weekly Report: what happened at RVTY last week (0615-0619)?
Weekly Report · 2d ago
Is Revvity Stock Underperforming the Nasdaq?
Barchart · 5d ago
Revvity Rated Buy on Improving Fundamentals and Undervaluation; $120 Price Target Reaffirmed
TipRanks · 6d ago
Revvity (RVTY) Stock Could Be 10.9% Undervalued Despite Profit And Growth Pressure
Simply Wall St · 06/17 05:25
Are Revvity’s Slowing Organic Gains Quietly Rewriting Its Margin-Led Growth Story (RVTY)?
Simply Wall St · 06/16 03:29
Weekly Report: what happened at RVTY last week (0608-0612)?
Weekly Report · 06/15 09:50
How Investors May Respond To Revvity (RVTY) Divesting Its China Immunodiagnostics Business
Simply Wall St · 06/08 17:17
Weekly Report: what happened at RVTY last week (0601-0605)?
Weekly Report · 06/08 09:48
Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus
Seeking Alpha · 06/07 13:05
A Look At Revvity (RVTY) Valuation After Recent Share Price Momentum And Margin Expansion Narrative
Simply Wall St · 06/05 06:24
These 10 large-cap U.S. healthcare companies carry the market's most expensive valuations
Seeking Alpha · 06/02 14:00
Wolfe Research Assumes Revvity at Peer Perform
Benzinga · 06/02 11:28
Weekly Report: what happened at RVTY last week (0525-0529)?
Weekly Report · 06/01 09:50
Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus
Seeking Alpha · 05/31 13:05
Is Danaher Stock Underperforming the S&P 500?
Barchart · 05/29 09:28
Revvity Inc. Stock Advances 4.6%, Outperforms Peers
Dow Jones · 05/28 20:35
More
Webull provides a variety of real-time RVTY stock news. You can receive the latest news about Revvity Inc through multiple platforms. This information may help you make smarter investment decisions.
About RVTY
Revvity, Inc. provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. It has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards life sciences customers. The segment offers instruments, reagents, software, subscriptions, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the areas of reproductive health and emerging market diagnostics. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.